Diane A. Sauter, MD, MS, is an attending physician, Department of Emergency Medicine, MedStar Washington Hospital Center (MWHC) and MedStar Georgetown University Hospital (MGUH). In addition, she is an assistant clinical professor of Emergency Medicine at the Georgetown University School of Medicine.
With subspecialty certification in Medical Toxicology, Dr. Sauter is an active participant in research pertaining to asthmatic emergencies, management of hemodynamic compromise in the poisoned patient, management of sickle cell pain crises, and drug-induced emergencies. Her research has been published in peer-reviewed journals, including The American Journal of Emergency Medicine, Chest, Annals of Emergency Medicine, and The Journal of Emergency Medicine. She serves as a consultant for Annals of Emergency Medicine. Topics of chapters she has published include drug use and abuse during pregnancy, toxicological emergencies, and caustic ingestions.
Dr. Sauter is a fellow of the American College of Emergency Physicians (ACEP), and she holds memberships in ACEP’s Research, Residency Directors and Toxicology sections. In addition, she is a member of the Education Committee of the American College of Medical Toxicology. She is certified by the American Board of Emergency Medicine and the American Board of Medical Toxicology.
At MWHC, she is a member of the Practice Committee. Her prior experience includes serving as an attending physician in the Department of Emergency Medicine at Children’s National Medical Center. Honors she has earned include a commendation from the Accreditation Council for Graduate Medical Education for her work as residency director for the Program in Emergency Medicine at the Metropolitan Hospital Center in New York City. Currently, she serves on the Board of Directors for the Langley Park Boys and Girls Club.
Her medical degree is from the State University of New York at Stony Brook. She continued her training with an internship and residency in emergency medicine at Metropolitan Hospital and a fellowship in medical toxicology at New York University, Bellevue Hospital Center/New York City Poison Control Center. Her master of science degree is from Drexel University College of Medicine.
Dr. Sauter’s research interests include the following:
- Medical toxicology
- Management of angioedema associated with angiotensin converting enzyme (ACE) inhibitors
- Novel agents for sickle cell crises
- Toxicity of designer drugs
- Minority participation in clinical trials
- Treatment of acute asthma
- Phencyclidine (PCP)-intoxicated patients
- Prophylaxis for contrast-induced nephropathy
- Management of hemodynamic compromise in the poisoned patient
- Cardiopulmonary arrest
Safety and Efficacy of Rivipansel for the Management of Pain Associated with Sickle Cell Vaso-Occlusive Crisis
Dr. Sauter is a principal investigator for this phase 3 multicenter, randomized clinical trial investigating the safety and efficacy of a new agent (Rivipansel) for the management of pain in patients hospitalized for a sickle cell vaso-occlusive crisis. This study is being sponsored by Pfizer.
Seasonal Variations in Incidence of ACE Inhibitor-Induced Angioedema
Dr. Sauter is a principal investigator on this retrospective clinical study evaluating seasonal variation in incidence of ACE-inhibitor induced angioedema. Some results of this work have been published in Annals of Allergy, Asthma and Immunology (2014 Feb;112:178-9. doi: 10.1016/j.anai.2013.11.016.).
Safety and Efficacy of Icatibant for Treatment of ACE Inhibitor-Induced Angioedema
Dr. Sauter was a principal investigator for this phase 3 multicenter clinical trial investigating the safety and efficacy of icatibant for the treatment of patients with ACE inhibitor-induced angioedema. This study was sponsored by Shire.
- Research Areas
- Critical Care/Emergency Medicine